400 related articles for article (PubMed ID: 2337670)
1. PPACK-thrombin inhibits thrombin-induced platelet aggregation and cytoplasmic acidification but does not inhibit platelet shape change.
Greco NJ; Tenner TE; Tandon NN; Jamieson GA
Blood; 1990 May; 75(10):1989-90. PubMed ID: 2337670
[TBL] [Abstract][Full Text] [Related]
2. Activation of platelets by alpha-thrombin is a receptor-mediated event. D-phenylalanyl-L-prolyl-L-arginine chloromethyl ketone-thrombin, but not N alpha-tosyl-L-lysine chloromethyl ketone-thrombin, binds to the high affinity thrombin receptor.
Harmon JT; Jamieson GA
J Biol Chem; 1986 Dec; 261(34):15928-33. PubMed ID: 3023333
[TBL] [Abstract][Full Text] [Related]
3. Changes in cytoplasmic pH in platelets activated through the high- and moderate-affinity receptor pathways by highly purified human alpha-thrombin.
Jones GD; Tenner TE; Greco NJ; Kitagawa S; Tandon NN; Jamieson GA
J Lab Clin Med; 1993 May; 121(5):662-7. PubMed ID: 8386738
[TBL] [Abstract][Full Text] [Related]
4. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
5. Conditions affecting the responses of human platelets to epinephrine.
Lalau Keraly C; Kinlough-Rathbone RL; Packham MA; Suzuki H; Mustard JF
Thromb Haemost; 1988 Oct; 60(2):209-16. PubMed ID: 3217918
[TBL] [Abstract][Full Text] [Related]
6. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl).
Rand ML; Neiman J; Jakowec DM; Packham MA
Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation by thrombin in the absence of the high-affinity thrombin receptor.
Harmon JT; Jamieson GA
Biochemistry; 1988 Mar; 27(6):2151-7. PubMed ID: 2837284
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
9. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility and temporal stability of ADP-induced platelet aggregation: comparison of the anticoagulants sodium citrate and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone.
Horne WC; Anderson GM; Cohen DJ
Am J Hematol; 1991 Sep; 38(1):48-53. PubMed ID: 1897514
[TBL] [Abstract][Full Text] [Related]
11. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
12. A new congenital defect of platelet secretion: impaired responsiveness of the platelets to cytoplasmic free calcium.
Hardisty RM; Machin SJ; Nokes TJ; Rink TJ; Smith SW
Br J Haematol; 1983 Apr; 53(4):543-57. PubMed ID: 6830700
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of a 100 kDa membrane protein (aggregin) during thrombin-induced platelet aggregation is mediated by the high affinity thrombin receptors.
Puri RN; Zhou FX; Colman RF; Colman RW
Biochem Biophys Res Commun; 1989 Aug; 162(3):1017-24. PubMed ID: 2475104
[TBL] [Abstract][Full Text] [Related]
14. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
15. Platelet shape change and Ca2+ mobilization induced by collagen, but not thrombin or ADP, are inhibited by phenylarsine oxide.
Greenwalt DE; Tandon NN
Br J Haematol; 1994 Dec; 88(4):830-8. PubMed ID: 7819106
[TBL] [Abstract][Full Text] [Related]
16. Thrombin binding to platelets defines functional receptors: inhibition of thrombin-induced platelet activation by catalytically-inactivated thrombin.
Greco NJ; Tandon NN; Jamieson GA
Platelets; 1995; 6(5):270-4. PubMed ID: 21043712
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation.
Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF
Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
19. A peptide ligand of the human thrombin receptor antagonizes alpha-thrombin and partially activates platelets.
Rasmussen UB; Gachet C; Schlesinger Y; Hanau D; Ohlmann P; Van Obberghen-Schilling E; Pouysségur J; Cazenave JP; Pavirani A
J Biol Chem; 1993 Jul; 268(19):14322-8. PubMed ID: 8390990
[TBL] [Abstract][Full Text] [Related]
20. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
Lückhoff A; Bohnert M; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
